Seizure management in acute hepatic porphyria
- 1 June 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 30 (6) , 588
- https://doi.org/10.1212/wnl.30.6.588
Abstract
Seizures may occur in acute intermittent porphyria or other hepatic porphyrias. Management is difficult, because barbiturates and hydantoins exacerbate the porphyric state. One patient with major motor seizures and acute intermittent porphyria was studied. The seizure disorder was exacerbated by phenytoin and did not respond to a high-carbohydrate diet or to i.v. hematin. Clonazepam was ineffective in treating the seizures and, in high doses, seemed to exacerbate the porphyria. Clonazepam and valproate were porphyrinogenic in experimental test systems. Because both drugs may exacerbate the acute hepatic porphyrias, bromide remains the drug of choice to treat these seizures.This publication has 2 references indexed in Scilit:
- Effect of Lead on Hepatic δ-Aminolaevulinic Acid Synthetase Activity in the Rat: A Model for Drug Sensitivity in Intermittent Acute PorphyriaEuropean Journal of Clinical Investigation, 1976
- The determination of aminoketones in biological fluidsAnalytical Biochemistry, 1966